Allstate (NYSE:ALL) Price Target Raised to $235.00 at UBS Group

Allstate (NYSE:ALL - Get Free Report) had its target price boosted by UBS Group from $230.00 to $235.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has a "buy" rating on the insurance provider's stock. UBS Group's price target suggests a potential upside of 21.64% from the stock's current price.

Several other equities analysts have also recently commented on the stock. Barclays raised their target price on shares of Allstate from $172.00 to $188.00 and gave the company an "underweight" rating in a research note on Monday. BMO Capital Markets reissued an "outperform" rating on shares of Allstate in a research note on Friday, May 16th. Evercore ISI raised their target price on shares of Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a research note on Thursday, May 1st. Wall Street Zen raised shares of Allstate from a "hold" rating to a "buy" rating in a research note on Thursday, May 1st. Finally, Morgan Stanley lifted their price objective on shares of Allstate from $225.00 to $235.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 6th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $227.07.

Allstate Stock Performance

NYSE:ALL traded down $1.48 during mid-day trading on Wednesday, hitting $193.20. The stock had a trading volume of 1,049,203 shares, compared to its average volume of 1,638,349. The stock has a market capitalization of $51.16 billion, a price-to-earnings ratio of 13.20, a P/E/G ratio of 1.01 and a beta of 0.33. The company has a 50 day simple moving average of $201.11 and a 200-day simple moving average of $196.67. Allstate has a 52 week low of $158.04 and a 52 week high of $213.18. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.40.

Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Wednesday, April 30th. The insurance provider reported $3.53 EPS for the quarter, missing the consensus estimate of $3.98 by ($0.45). The company had revenue of $14.30 billion for the quarter, compared to analyst estimates of $16.41 billion. Allstate had a net margin of 6.19% and a return on equity of 24.62%. The firm's quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the business posted $5.13 EPS. On average, research analysts expect that Allstate will post 18.74 earnings per share for the current fiscal year.

Institutional Trading of Allstate

Institutional investors have recently made changes to their positions in the stock. Arlington Trust Co LLC lifted its stake in shares of Allstate by 261.8% in the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider's stock worth $25,000 after buying an additional 89 shares during the last quarter. VSM Wealth Advisory LLC acquired a new stake in shares of Allstate in the fourth quarter worth $25,000. Hughes Financial Services LLC acquired a new stake in shares of Allstate in the first quarter worth $28,000. Twin Tree Management LP acquired a new stake in shares of Allstate in the fourth quarter worth $27,000. Finally, Hopwood Financial Services Inc. acquired a new stake in shares of Allstate in the fourth quarter worth $29,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.